These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 33153499)
1. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model. Kim SH; Ahn JH; Yang H; Lee P; Koh GY; Jeong Y Acta Neuropathol Commun; 2020 Nov; 8(1):181. PubMed ID: 33153499 [TBL] [Abstract][Full Text] [Related]
2. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β. Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628 [TBL] [Abstract][Full Text] [Related]
3. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379 [TBL] [Abstract][Full Text] [Related]
4. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896 [TBL] [Abstract][Full Text] [Related]
5. Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Albargothy NJ; Johnston DA; MacGregor-Sharp M; Weller RO; Verma A; Hawkes CA; Carare RO Acta Neuropathol; 2018 Jul; 136(1):139-152. PubMed ID: 29754206 [TBL] [Abstract][Full Text] [Related]
6. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684 [TBL] [Abstract][Full Text] [Related]
7. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Hawkes CA; Härtig W; Kacza J; Schliebs R; Weller RO; Nicoll JA; Carare RO Acta Neuropathol; 2011 Apr; 121(4):431-43. PubMed ID: 21259015 [TBL] [Abstract][Full Text] [Related]
8. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230 [TBL] [Abstract][Full Text] [Related]
9. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain. Hawkes CA; Gatherer M; Sharp MM; Dorr A; Yuen HM; Kalaria R; Weller RO; Carare RO Aging Cell; 2013 Apr; 12(2):224-36. PubMed ID: 23413811 [TBL] [Abstract][Full Text] [Related]
10. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Hawkes CA; Jayakody N; Johnston DA; Bechmann I; Carare RO Brain Pathol; 2014 Jul; 24(4):396-403. PubMed ID: 24946077 [TBL] [Abstract][Full Text] [Related]
11. Lead Acetate Exposure and Cerebral Amyloid Accumulation: Mechanistic Evaluations in APP/PS1 Mice. Gu H; Liu LL; Wu A; Yu Y; Emir U; Sawiak SJ; Territo PR; Farlow MR; Zheng W; Du Y Environ Health Perspect; 2024 Oct; 132(10):107004. PubMed ID: 39412896 [TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Weller RO; Nicoll JA Neurol Res; 2003 Sep; 25(6):611-6. PubMed ID: 14503015 [TBL] [Abstract][Full Text] [Related]
13. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease. Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995 [TBL] [Abstract][Full Text] [Related]
14. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833 [TBL] [Abstract][Full Text] [Related]
15. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340 [TBL] [Abstract][Full Text] [Related]
16. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring. Hawkes CA; Gentleman SM; Nicoll JA; Carare RO J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857 [TBL] [Abstract][Full Text] [Related]
17. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284 [TBL] [Abstract][Full Text] [Related]
18. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Weller RO; Subash M; Preston SD; Mazanti I; Carare RO Brain Pathol; 2008 Apr; 18(2):253-66. PubMed ID: 18363936 [TBL] [Abstract][Full Text] [Related]
19. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. Haglund M; Kalaria R; Slade JY; Englund E Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084 [TBL] [Abstract][Full Text] [Related]
20. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice. Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]